-+ 0.00%
-+ 0.00%
-+ 0.00%

HealthEquity Affirms FY2026 Adj EPS Guidance of $3.87-$3.95 vs $3.95 Est; Affirms FY2026 Sales Guidance of $1.302B-$1.312B vs $1.311B Est

Benzinga·02/17/2026 22:40:23
Listen to the news
HealthEquity (NASDAQ:HQY) affirms FY2026 Adj EPS guidance from $3.87-$3.95 to $3.87-$3.95 vs $3.95 analyst estimate. Affirms FY2026 sales outlook from $1.302 billion-$1.312 billion to $1.302 billion-$1.312 billion vs $1.311 billion estimate.